Tokyo, Japan

Kiyohiko Hatake

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Morinaga Milk Industry Co., Ltd.. Active years: 2008.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kiyohiko Hatake: Innovator in Cancer Therapy

Introduction

Kiyohiko Hatake is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on enhancing the efficacy of antibody drugs used in cancer treatment.

Latest Patents

Kiyohiko Hatake holds a patent for a drug designed for cancer therapy. This patent involves a lactoferrin hydrolysate mixture or lactoferrin partial peptide that is obtained by hydrolyzing lactoferrin with a hydrolytic enzyme. The active ingredient enhances the cytotoxic activity of an antibody drug in antibody therapy for cancer.

Career Highlights

Throughout his career, Kiyohiko Hatake has worked with prominent companies such as Morinaga Milk Industry Co., Ltd. and Olympus Corporation. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Kiyohiko has collaborated with notable coworkers, including Yasuhito Terui and Yuji Mishima. Their combined efforts have further advanced the research and development of cancer therapies.

Conclusion

Kiyohiko Hatake's contributions to cancer therapy through his innovative patent and collaborations highlight his role as a significant inventor in the field. His work continues to impact the development of effective treatments for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…